Shots:
- Xenix Medical has received the US FDA 510(k) clearance & initiated the full commercial launch of its Lux Expandable Lumbar Interbody Fusion System
- Lux features up to 4.5mm of controlled post-implant expansion, enables bone graft delivery through the inserter into a large endplate-to-endplate graft window after expansion, & incorporates NanoACTIV surface tech. to support fusion outcomes
- Lux also incorporates NeoWave matrix architecture, featuring uniform edge-to-edge porosity & an internal serpentine wall design that helps reduce stiffness, minimize point loading, & lower the risk of subsidence
Ref: Businesswire | Image: Xenix Medical | Press Release
Related News: Signati Medical Receives FDA IDE Approval for Pivotal Trial of Separo Vasectomy System
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
